Successful treatment of visceral leishmaniasis with liposomal amphotericin B

Acta Biomedica de l'Ateneo Parmense

Volumn 77, Issue SUPPL. 2, 2006, Pages 22-25

  Lagler, Heimo ^a   Matt, Ulrich ^a   Sillaber, Christian ^a   Winkler, Stefan ^a   Graninger, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Fever of unknown origin; Liposomal amphotericin B; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX;

ADULT; AMASTIGOTE; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; KENYA; LABORATORY TEST; LEISHMANIA INFANTUM; PHYSICAL EXAMINATION; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

ADULT; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; AUSTRIA; FEMALE; FEVER; HUMANS; KENYA; LEISHMANIASIS, VISCERAL; LIPOSOMES; REMISSION INDUCTION;

EID: 33845288613     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. WHO. The World Health Report 2000. Geneva: WHO, 2000.
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol, Microbiol and Infectious Diseases 2004; 27: 305-18.
3. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in Leishmaniasis. Lancet 2005; 366: 1561-77.
4. Olliaro PL, Guerin PJ, Gerstl S, Haaskjold AA, Rottingen JA, Sundar S. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005; 5: 763-74.
5. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 2001; 6: 849-54.
6. Guerin PJ, Olliaro P, Sundar S, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501.
7. Sundar S, Mehta H, Suresh AV, et al. Amphotericin B treatment for Indian visceral Leishmaniasis: conventional versus lipid formulations. Clin Infect Dis 2004; 38: 377-83.
8. Sundar S, Jha TK, Thakur CP et al. Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. Am J Trop Med Hyg 2002; 66: 143-6.
9. Drugs for Parasitic Infections. Med Lett Drugs Ther; August 2004. Online: www.medletter.com/freedocs/parasitic.pdf (Accessed 3/8/05).
10. Sudar S, Agrawal G, Rai M, Makharia MK, Murray HW. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. BMJ 2001; 323: 419-22.